Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5419306

CC(C)(C)c1ccc(Cn2c(-c3ccccc3)c(CN3CCC(c4c(Cl)cccc4Cl)CC3)c3ccccc32)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 3/20 0.43
HDAC8 Q9BY41 2/20 0.43
HDAC2 Q92769 1/20 0.43
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
MCHR1 Q99705 1/20 0.39
HDAC1 Q13547 2/20 0.39
PAX8 Q06710 1/20 0.38
HTR2A P28223 1/20 0.38
TP53 P04637 3/20 0.37
THRB P10828 1/20 0.37
SERPINE1 P05121 1/20 0.37
AKR1B10 O60218 1/20 0.37
AKR1B1 P15121 1/20 0.37
KCNH2 Q12809 1/20 0.36
DRD4 P21917 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5415360 0.93 HDAC6 (0.44) HDAC6HDAC8HDAC2HDAC1PAX8
Trifluoroacetic Acid SCHEMBL5420943 0.92 HDAC6 (0.44) HDAC6HDAC8HDAC2HDAC1PAX8
Trifluoroacetic Acid SCHEMBL5423556 0.90 PAX8 (0.45) HDAC6HDAC8HDAC2MEN1KMT2A
Trifluoroacetic Acid SCHEMBL5417447 0.89 BCHE (0.43) HDAC6HDAC8HDAC2MEN1KMT2A
Trifluoroacetic Acid SCHEMBL5427703 0.88 GPR6 (0.43) HDAC6HDAC8HDAC2HTR2ATP53
Trifluoroacetic Acid SCHEMBL5414004 0.88 HDAC2 (0.41) HDAC6HDAC8HDAC2MCHR1PAX8
Trifluoroacetic Acid SCHEMBL5415319 0.88 ALDH1A2 (0.46) MEN1KMT2AMCHR1KCNH2DRD4
Trifluoroacetic Acid SCHEMBL5419379 0.88 GPR6 (0.44) HDAC6HDAC8HDAC2HTR2ATP53
Trifluoroacetic Acid SCHEMBL5411590 0.87 ALDH1A1 (0.45) HDAC6HDAC8HDAC2MEN1KMT2A
Trifluoroacetic Acid SCHEMBL5422830 0.85 LMNA (0.41) HDAC6HDAC8HDAC2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070197603-A1 Substituted indole ligands for the orl-1 receptor GLAXOSMITHKLINE S.P.A. (IT) 2007-08-23 US claimed
EP-1648881-A1 SUBSTITUTED INDOLE LIGANDS FOR THE ORL-1 RECEPTOR GlaxoSmithKline S.p.A. (IT) 2006-04-26 EP claimed
WO-2005005411-A1 SUBSTITUTED INDOLE LIGANDS FOR THE ORL-1 RECEPTOR GLAXOSMITHKLINE S.P.A. (IT) 2005-01-20 WO claimed
US-20070197603-A1 Substituted indole ligands for the orl-1 receptor GLAXOSMITHKLINE S.P.A. (IT) 2007-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197603-A1 Substituted indole ligands for the orl-1 receptor OGFRL1, OPRL1, ORMDL3 HDAC6 3419/4885HDAC8 3562/4885HDAC2 2261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.